The Indian government said coronavirus test kits manufactured by Chinese companies Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics, found to be “under-performing” by the Indian Council of Medical Research (ICMR).
Just after the announcement, the government announced today, not a single rupee will be lost to these Chinese firms and dismissed all the orders.
A controversy erupted between the distributor and the importer in the Delhi High Court suggesting that India had paid double. The test kits were imported from China by the importer, Matrix, for Rs. 245/piece. But, the distributors, Real Metabolics and Aark Pharmaceuticals, sold the same kits to the government for Rs 600 each.
The government, through the Indian Council of Medical Research (ICMR) , had ordered five lakh rapid antibody test kits from Chinese firm Wondfo on March 27. All the states and hospitals were asked to stop using the kits.
Nearly 5 lakh rapid antibody test kits and RNA Extraction Kits were procured by the government and distributed countrywide earlier this month. The move was taken as the ICMR suggested that every resident in coronavirus hotspots will be tested for the virus.
West Bengal, Rajasthan and several other states complained about the new test kits not working properly and they had 5.4 percent accuracy. The opposition parties questioned the government’s purchase as well. The government in its clarification said it had conducted a tender process and did not pay in advance for any antibody test kits.